UM1DA058220

Mosaicism in Human Tissues, from Telomere to Telomere to RFA-22-013: "Somatic Mosaicism Across Human Tissues Program: Genome Characterization Centers" - Project Summary

Precision genomic medicine depends on a complete understanding of all forms of genetic variation in normal individuals. However, current approaches for studying genetic variation in humans have yielded an incomplete snapshot of somatic variation and its contribution to health and disease. This is because current approaches typically sequence a single tissue (blood) and are not well suited for identifying structural variants, variants in repeat elements, or the functional consequences of somatic variants.

The goal of our proposal, "Mosaicism in Human Tissues, from Telomere to Telomere," is to characterize multiple types of human somatic variation across the entire human genome in a set of 10 tissues from 50 donors. Additionally, we aim to work with other SMAHT Network members towards producing a framework for understanding somatic variation in non-pathological human tissues.

To advance these goals, our GCC will use a highly successful pipeline that has produced tens of thousands of high-quality human genomes, including the first-ever complete telomere-to-telomere human genome. We will produce high-quality short and long-read DNA sequencing data, full-length transcript RNA sequencing data, single-molecule chromatin profiling data, and long-range chromatin conformation data from each donor.

This approach will enable us to generate donor-specific reference genome assemblies, which we will use to call somatic variants in their originating haplotype genomic context. Calling variants independent of traditionally incomplete human references will vastly improve our ability to accurately identify somatic variants in complex repeat regions and other "unmappable" areas. These regions are precisely the locations where somatic mutation rate is expected to be elevated because they are challenging for the cell's endogenous replication and proofreading mechanisms.

Additionally, our approach will enable us to directly interrogate the impact of identified somatic variants on overlying epigenetic and transcriptional gene regulatory patterns. This GCC brings together three internationally recognized principal investigators (Drs. Bennett, Eichler, and Stergachis), with decades of expertise in high-throughput genomics, somatic variant discovery, structural variant identification, long-read sequencing, and chromatin biology.

Along with other members of the SMAHT Network, we will produce the most complete catalogue of somatic variation and its gene regulatory impact to date.

Seattle Children's Hospital

NOT APPLICABLE

93.310 - Trans-NIH Research Support

National Institute on Drug Abuse (NIDA) [HHS - NIH]

National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]

Seattle, Washington 98101 United States

Single Zip Code

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) (RFA-RM-22-013)

Amendment Since initial award the total obligations have increased 236% from $2,499,999 to $8,410,614.